#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Biomedical applications of metallic oxide nanoparticles are recently considered an interesting avenue of research regarding nano-biotechnology .
3-1	17-27	Biomedical	abstract[3]	new[3]	coref	4-16[12_3]
3-2	28-40	applications	abstract[3]	new[3]	_	_
3-3	41-43	of	abstract[3]	new[3]	_	_
3-4	44-52	metallic	abstract[3]|object[5]	new[3]|new[5]	coref	4-1[0_5]
3-5	53-58	oxide	abstract[3]|abstract|object[5]	new[3]|new|new[5]	coref	5-11
3-6	59-72	nanoparticles	abstract[3]|object[5]	new[3]|new[5]	_	_
3-7	73-76	are	_	_	_	_
3-8	77-85	recently	_	_	_	_
3-9	86-96	considered	_	_	_	_
3-10	97-99	an	abstract[6]	new[6]	_	_
3-11	100-111	interesting	abstract[6]	new[6]	_	_
3-12	112-118	avenue	abstract[6]	new[6]	_	_
3-13	119-121	of	abstract[6]	new[6]	_	_
3-14	122-130	research	abstract[6]|abstract	new[6]|new	_	_
3-15	131-140	regarding	_	_	_	_
3-16	141-159	nano-biotechnology	_	_	_	_
3-17	160-161	.	_	_	_	_

#Text=Nanoparticles possess unique physio-chemical , optical and electro-magnetic properties that make them appropriate tools for various applications in the field of materials science and pharmacy .
4-1	162-175	Nanoparticles	object	giv	coref	5-10[21_0]
4-2	176-183	possess	_	_	_	_
4-3	184-190	unique	abstract[9]	new[9]	ana	4-12[0_9]
4-4	191-206	physio-chemical	abstract[9]	new[9]	_	_
4-5	207-208	,	abstract[9]	new[9]	_	_
4-6	209-216	optical	abstract[9]	new[9]	_	_
4-7	217-220	and	abstract[9]	new[9]	_	_
4-8	221-237	electro-magnetic	abstract[9]	new[9]	_	_
4-9	238-248	properties	abstract[9]	new[9]	_	_
4-10	249-253	that	_	_	_	_
4-11	254-258	make	_	_	_	_
4-12	259-263	them	abstract	giv	coref	14-3[91_0]
4-13	264-275	appropriate	object[11]	new[11]	_	_
4-14	276-281	tools	object[11]	new[11]	_	_
4-15	282-285	for	_	_	_	_
4-16	286-293	various	abstract[12]	giv[12]	coref	14-20[97_12]
4-17	294-306	applications	abstract[12]	giv[12]	_	_
4-18	307-309	in	abstract[12]	giv[12]	_	_
4-19	310-313	the	abstract[12]|abstract[13]	giv[12]|new[13]	_	_
4-20	314-319	field	abstract[12]|abstract[13]	giv[12]|new[13]	_	_
4-21	320-322	of	abstract[12]|abstract[13]	giv[12]|new[13]	_	_
4-22	323-332	materials	abstract[12]|abstract[13]|substance|abstract[15]	giv[12]|new[13]|new|new[15]	_	_
4-23	333-340	science	abstract[12]|abstract[13]|abstract[15]	giv[12]|new[13]|new[15]	_	_
4-24	341-344	and	abstract[12]|abstract[13]	giv[12]|new[13]	_	_
4-25	345-353	pharmacy	abstract[12]|abstract[13]|abstract	giv[12]|new[13]|new	_	_
4-26	354-355	.	_	_	_	_

#Text=Co-precipitation is the most adaptive method for preparation of metallic oxide nanoparticles because of its reproducibility and cheapness .
5-1	356-372	Co-precipitation	abstract	new	coref	5-3[18_0]
5-2	373-375	is	_	_	_	_
5-3	376-379	the	abstract[18]	giv[18]	_	_
5-4	380-384	most	abstract[18]	giv[18]	_	_
5-5	385-393	adaptive	abstract[18]	giv[18]	_	_
5-6	394-400	method	abstract[18]	giv[18]	_	_
5-7	401-404	for	abstract[18]	giv[18]	_	_
5-8	405-416	preparation	abstract[18]|abstract[19]	giv[18]|new[19]	_	_
5-9	417-419	of	abstract[18]|abstract[19]	giv[18]|new[19]	_	_
5-10	420-428	metallic	abstract[18]|abstract[19]|object[21]	giv[18]|new[19]|giv[21]	coref	6-6[0_21]
5-11	429-434	oxide	abstract[18]|abstract[19]|abstract|object[21]	giv[18]|new[19]|giv|giv[21]	_	_
5-12	435-448	nanoparticles	abstract[18]|abstract[19]|object[21]	giv[18]|new[19]|giv[21]	_	_
5-13	449-456	because	abstract[18]|abstract[19]	giv[18]|new[19]	_	_
5-14	457-459	of	abstract[18]|abstract[19]	giv[18]|new[19]	_	_
5-15	460-463	its	abstract[18]|abstract[19]|abstract[22]	giv[18]|new[19]|new[22]	_	_
5-16	464-479	reproducibility	abstract[18]|abstract[19]|abstract[22]	giv[18]|new[19]|new[22]	_	_
5-17	480-483	and	abstract[18]|abstract[19]	giv[18]|new[19]	_	_
5-18	484-493	cheapness	abstract[18]|abstract[19]|abstract	giv[18]|new[19]|new	_	_
5-19	494-495	.	_	_	_	_

#Text=Titanium dioxide ( TiO2 ) nanoparticles have been vastly synthesized by different chemical routes .
6-1	496-504	Titanium	person|abstract[25]	new|new[25]	_	_
6-2	505-512	dioxide	abstract[25]	new[25]	_	_
6-3	513-514	(	_	_	_	_
6-4	515-519	TiO2	substance	new	coref	8-3
6-5	520-521	)	_	_	_	_
6-6	522-535	nanoparticles	object	giv	coref	7-5
6-7	536-540	have	_	_	_	_
6-8	541-545	been	_	_	_	_
6-9	546-552	vastly	_	_	_	_
6-10	553-564	synthesized	_	_	_	_
6-11	565-567	by	_	_	_	_
6-12	568-577	different	abstract[28]	new[28]	_	_
6-13	578-586	chemical	abstract[28]	new[28]	_	_
6-14	587-593	routes	abstract[28]	new[28]	_	_
6-15	594-595	.	_	_	_	_

#Text=Doping prevents aggregation between nanoparticles ultimately leading to their stability , longevity as well as intensified reactivity .
7-1	596-602	Doping	substance	new	_	_
7-2	603-611	prevents	_	_	_	_
7-3	612-623	aggregation	abstract[30]	new[30]	_	_
7-4	624-631	between	abstract[30]	new[30]	_	_
7-5	632-645	nanoparticles	abstract[30]|object	new[30]|giv	ana	7-9
7-6	646-656	ultimately	_	_	_	_
7-7	657-664	leading	_	_	_	_
7-8	665-667	to	_	_	_	_
7-9	668-673	their	object|abstract[33]	giv|new[33]	coref|coref	8-3[37_0]|8-3[37_0]
7-10	674-683	stability	abstract[33]	new[33]	_	_
7-11	684-685	,	_	_	_	_
7-12	686-695	longevity	abstract	new	_	_
7-13	696-698	as	_	_	_	_
7-14	699-703	well	_	_	_	_
7-15	704-706	as	_	_	_	_
7-16	707-718	intensified	abstract[35]	new[35]	_	_
7-17	719-729	reactivity	abstract[35]	new[35]	_	_
7-18	730-731	.	_	_	_	_

#Text=Hence , TiO2 nanoparticles have been doped with Ni , Cu , Fe , Mo , N and other metals using hydrolysis , precipitation , sol-gel and other methods for fabrication in the past .
8-1	732-737	Hence	_	_	_	_
8-2	738-739	,	_	_	_	_
8-3	740-744	TiO2	substance|object[37]	giv|giv[37]	coref|coref|coref|coref	9-2|9-1[50_37]|9-2|9-1[50_37]
8-4	745-758	nanoparticles	object[37]	giv[37]	_	_
8-5	759-763	have	_	_	_	_
8-6	764-768	been	_	_	_	_
8-7	769-774	doped	_	_	_	_
8-8	775-779	with	_	_	_	_
8-9	780-782	Ni	person	new	_	_
8-10	783-784	,	_	_	_	_
8-11	785-787	Cu	person	new	coref	12-9
8-12	788-789	,	_	_	_	_
8-13	790-792	Fe	person	new	coref	12-11
8-14	793-794	,	_	_	_	_
8-15	795-797	Mo	person	new	_	_
8-16	798-799	,	_	_	_	_
8-17	800-801	N	person	new	_	_
8-18	802-805	and	_	_	_	_
8-19	806-811	other	substance[43]	new[43]	_	_
8-20	812-818	metals	substance[43]	new[43]	_	_
8-21	819-824	using	_	_	_	_
8-22	825-835	hydrolysis	substance	new	_	_
8-23	836-837	,	_	_	_	_
8-24	838-851	precipitation	substance	new	_	_
8-25	852-853	,	_	_	_	_
8-26	854-861	sol-gel	_	_	_	_
8-27	862-865	and	_	_	_	_
8-28	866-871	other	abstract[46]	new[46]	_	_
8-29	872-879	methods	abstract[46]	new[46]	_	_
8-30	880-883	for	abstract[46]	new[46]	_	_
8-31	884-895	fabrication	abstract[46]|animal[47]	new[46]|new[47]	_	_
8-32	896-898	in	abstract[46]|animal[47]	new[46]|new[47]	_	_
8-33	899-902	the	abstract[46]|animal[47]|time[48]	new[46]|new[47]|new[48]	_	_
8-34	903-907	past	abstract[46]|animal[47]|time[48]	new[46]|new[47]|new[48]	_	_
8-35	908-909	.	_	_	_	_

#Text=Metal-doped TiO2 nanoparticles serve many environmental remediation purposes like removal of organic dyes and wastes/pollutants owing to their tremendous photocatalytic activity .
9-1	910-921	Metal-doped	object[50]	giv[50]	coref	10-15[64_50]
9-2	922-926	TiO2	abstract|object[50]	giv|giv[50]	coref	10-12[62_0]
9-3	927-940	nanoparticles	object[50]	giv[50]	_	_
9-4	941-946	serve	_	_	_	_
9-5	947-951	many	abstract[52]	new[52]	_	_
9-6	952-965	environmental	abstract[52]	new[52]	_	_
9-7	966-977	remediation	abstract|abstract[52]	new|new[52]	_	_
9-8	978-986	purposes	abstract[52]	new[52]	_	_
9-9	987-991	like	abstract[52]	new[52]	_	_
9-10	992-999	removal	abstract[52]|event[53]	new[52]|new[53]	_	_
9-11	1000-1002	of	abstract[52]|event[53]	new[52]|new[53]	_	_
9-12	1003-1010	organic	abstract[52]|event[53]|substance[54]	new[52]|new[53]|new[54]	_	_
9-13	1011-1015	dyes	abstract[52]|event[53]|substance[54]	new[52]|new[53]|new[54]	_	_
9-14	1016-1019	and	abstract[52]|event[53]	new[52]|new[53]	_	_
9-15	1020-1037	wastes/pollutants	abstract[52]|event[53]|substance	new[52]|new[53]|new	ana	9-18
9-16	1038-1043	owing	_	_	_	_
9-17	1044-1046	to	_	_	_	_
9-18	1047-1052	their	substance|abstract[57]	giv|new[57]	ana|coref|ana|coref	10-4|10-7[61_57]|10-4|10-7[61_57]
9-19	1053-1063	tremendous	abstract[57]	new[57]	_	_
9-20	1064-1078	photocatalytic	abstract[57]	new[57]	_	_
9-21	1079-1087	activity	abstract[57]	new[57]	_	_
9-22	1088-1089	.	_	_	_	_

#Text=In context of their role in biomedicine , antibacterial activity of Mn-doped TiO2 and Nd-doped TiO2 nanoparticles has been documented .
10-1	1090-1092	In	_	_	_	_
10-2	1093-1100	context	abstract[58]	new[58]	_	_
10-3	1101-1103	of	abstract[58]	new[58]	_	_
10-4	1104-1109	their	abstract[58]|substance|abstract[60]	new[58]|giv|new[60]	coref|coref	17-12[132_60]|17-12[132_60]
10-5	1110-1114	role	abstract[58]|abstract[60]	new[58]|new[60]	_	_
10-6	1115-1117	in	_	_	_	_
10-7	1118-1129	biomedicine	abstract[61]	giv[61]	_	_
10-8	1130-1131	,	abstract[61]	giv[61]	_	_
10-9	1132-1145	antibacterial	abstract[61]	giv[61]	_	_
10-10	1146-1154	activity	abstract[61]	giv[61]	_	_
10-11	1155-1157	of	abstract[61]	giv[61]	_	_
10-12	1158-1166	Mn-doped	abstract[61]|substance[62]	giv[61]|giv[62]	coref	10-16[0_62]
10-13	1167-1171	TiO2	abstract[61]|substance[62]	giv[61]|giv[62]	_	_
10-14	1172-1175	and	abstract[61]	giv[61]	_	_
10-15	1176-1184	Nd-doped	abstract[61]|object[64]	giv[61]|giv[64]	coref	11-1[66_64]
10-16	1185-1189	TiO2	abstract[61]|abstract|object[64]	giv[61]|giv|giv[64]	coref	11-1
10-17	1190-1203	nanoparticles	abstract[61]|object[64]	giv[61]|giv[64]	_	_
10-18	1204-1207	has	_	_	_	_
10-19	1208-1212	been	_	_	_	_
10-20	1213-1223	documented	_	_	_	_
10-21	1224-1225	.	_	_	_	_

#Text=TiO2 nanoparticles have been proven important skin protecting agents against UV radiation and used in sunscreens/cosmetics as reported by Viana et al. .
11-1	1226-1230	TiO2	substance|object[66]	giv|giv[66]	coref|coref|coref|coref	12-3|12-3[75_66]|12-3|12-3[75_66]
11-2	1231-1244	nanoparticles	object[66]	giv[66]	_	_
11-3	1245-1249	have	_	_	_	_
11-4	1250-1254	been	_	_	_	_
11-5	1255-1261	proven	_	_	_	_
11-6	1262-1271	important	object[67]	new[67]	_	_
11-7	1272-1276	skin	object[67]	new[67]	_	_
11-8	1277-1287	protecting	_	_	_	_
11-9	1288-1294	agents	person[68]	new[68]	_	_
11-10	1295-1302	against	person[68]	new[68]	_	_
11-11	1303-1305	UV	person[68]|place|abstract[70]	new[68]|new|new[70]	_	_
11-12	1306-1315	radiation	person[68]|abstract[70]	new[68]|new[70]	_	_
11-13	1316-1319	and	_	_	_	_
11-14	1320-1324	used	_	_	_	_
11-15	1325-1327	in	_	_	_	_
11-16	1328-1348	sunscreens/cosmetics	object	new	_	_
11-17	1349-1351	as	_	_	_	_
11-18	1352-1360	reported	_	_	_	_
11-19	1361-1363	by	_	_	_	_
11-20	1364-1369	Viana	person	new	_	_
11-21	1370-1372	et	_	_	_	_
11-22	1373-1376	al.	_	_	_	_
11-23	1377-1378	.	_	_	_	_

#Text=Cytotoxicity of TiO2 nanoparticles doped with Ag , Cu , Fe has been validated against human cancer cell lines and hence these nanoparticles have been successfully declared anti-cancerous materials .
12-1	1379-1391	Cytotoxicity	abstract[73]	new[73]	coref	18-13[0_73]
12-2	1392-1394	of	abstract[73]	new[73]	_	_
12-3	1395-1399	TiO2	abstract[73]|abstract|object[75]	new[73]|giv|giv[75]	coref|coref|coref|coref	12-22[82_75]|13-10|12-22[82_75]|13-10
12-4	1400-1413	nanoparticles	abstract[73]|object[75]	new[73]|giv[75]	_	_
12-5	1414-1419	doped	_	_	_	_
12-6	1420-1424	with	_	_	_	_
12-7	1425-1427	Ag	substance	new	_	_
12-8	1428-1429	,	_	_	_	_
12-9	1430-1432	Cu	person	giv	_	_
12-10	1433-1434	,	_	_	_	_
12-11	1435-1437	Fe	substance	giv	_	_
12-12	1438-1441	has	_	_	_	_
12-13	1442-1446	been	_	_	_	_
12-14	1447-1456	validated	_	_	_	_
12-15	1457-1464	against	_	_	_	_
12-16	1465-1470	human	abstract[81]	new[81]	_	_
12-17	1471-1477	cancer	abstract|abstract[81]	new|new[81]	coref	15-54
12-18	1478-1482	cell	place|abstract[81]	new|new[81]	coref	15-34
12-19	1483-1488	lines	abstract[81]	new[81]	_	_
12-20	1489-1492	and	_	_	_	_
12-21	1493-1498	hence	_	_	_	_
12-22	1499-1504	these	object[82]	giv[82]	coref	13-9[87_82]
12-23	1505-1518	nanoparticles	object[82]	giv[82]	_	_
12-24	1519-1523	have	_	_	_	_
12-25	1524-1528	been	_	_	_	_
12-26	1529-1541	successfully	_	_	_	_
12-27	1542-1550	declared	_	_	_	_
12-28	1551-1565	anti-cancerous	_	_	_	_
12-29	1566-1575	materials	_	_	_	_
12-30	1576-1577	.	_	_	_	_

#Text=Regarding bioremediation studies , the photocatalytic property of N-doped TiO2 nanoparticles for air and water purification was exclusively described .
13-1	1578-1587	Regarding	_	_	_	_
13-2	1588-1602	bioremediation	abstract|abstract[84]	new|new[84]	_	_
13-3	1603-1610	studies	abstract[84]	new[84]	_	_
13-4	1611-1612	,	_	_	_	_
13-5	1613-1616	the	abstract[85]	new[85]	_	_
13-6	1617-1631	photocatalytic	abstract[85]	new[85]	_	_
13-7	1632-1640	property	abstract[85]	new[85]	_	_
13-8	1641-1643	of	abstract[85]	new[85]	_	_
13-9	1644-1651	N-doped	abstract[85]|object[87]	new[85]|giv[87]	coref	14-16[96_87]
13-10	1652-1656	TiO2	abstract[85]|abstract|object[87]	new[85]|giv|giv[87]	coref	14-17
13-11	1657-1670	nanoparticles	abstract[85]|object[87]	new[85]|giv[87]	_	_
13-12	1671-1674	for	abstract[85]|object[87]	new[85]|giv[87]	_	_
13-13	1675-1678	air	abstract[85]|object[87]|substance	new[85]|giv[87]|new	_	_
13-14	1679-1682	and	abstract[85]|object[87]	new[85]|giv[87]	_	_
13-15	1683-1688	water	abstract[85]|object[87]|substance|substance[90]	new[85]|giv[87]|new|new[90]	_	_
13-16	1689-1701	purification	abstract[85]|object[87]|substance[90]	new[85]|giv[87]|new[90]	_	_
13-17	1702-1705	was	_	_	_	_
13-18	1706-1717	exclusively	_	_	_	_
13-19	1718-1727	described	_	_	_	_
13-20	1728-1729	.	_	_	_	_

#Text=Talking about biomedical properties , Zane et al. reported the biocompatibility and antibacterial activity of N-doped TiO2 nanoparticles and its applications in dental resin formulations .
14-1	1730-1737	Talking	_	_	_	_
14-2	1738-1743	about	_	_	_	_
14-3	1744-1754	biomedical	abstract[91]	giv[91]	_	_
14-4	1755-1765	properties	abstract[91]	giv[91]	_	_
14-5	1766-1767	,	abstract[91]	giv[91]	_	_
14-6	1768-1772	Zane	abstract[91]|person	giv[91]|new	_	_
14-7	1773-1775	et	abstract[91]	giv[91]	_	_
14-8	1776-1779	al.	abstract[91]	giv[91]	_	_
14-9	1780-1788	reported	_	_	_	_
14-10	1789-1792	the	abstract[93]	new[93]	coref	15-38[113_93]
14-11	1793-1809	biocompatibility	abstract[93]	new[93]	_	_
14-12	1810-1813	and	_	_	_	_
14-13	1814-1827	antibacterial	abstract[94]	new[94]	_	_
14-14	1828-1836	activity	abstract[94]	new[94]	_	_
14-15	1837-1839	of	abstract[94]	new[94]	_	_
14-16	1840-1847	N-doped	abstract[94]|object[96]	new[94]|giv[96]	coref	15-10[103_96]
14-17	1848-1852	TiO2	abstract[94]|abstract|object[96]	new[94]|giv|giv[96]	coref	15-11
14-18	1853-1866	nanoparticles	abstract[94]|object[96]	new[94]|giv[96]	_	_
14-19	1867-1870	and	abstract[94]|object[96]	new[94]|giv[96]	_	_
14-20	1871-1874	its	abstract[94]|object[96]|abstract[97]	new[94]|giv[96]|giv[97]	_	_
14-21	1875-1887	applications	abstract[94]|object[96]|abstract[97]	new[94]|giv[96]|giv[97]	_	_
14-22	1888-1890	in	abstract[94]|object[96]|abstract[97]	new[94]|giv[96]|giv[97]	_	_
14-23	1891-1897	dental	abstract[94]|object[96]|abstract[97]|object[99]	new[94]|giv[96]|giv[97]|new[99]	_	_
14-24	1898-1903	resin	abstract[94]|object[96]|abstract[97]|person|object[99]	new[94]|giv[96]|giv[97]|new|new[99]	_	_
14-25	1904-1916	formulations	abstract[94]|object[96]|abstract[97]|object[99]	new[94]|giv[96]|giv[97]|new[99]	_	_
14-26	1917-1918	.	_	_	_	_

#Text=Moreover , the assessment of orthodontic brackets coated with N-doped TiO2 nanoparticles against Streptococcus mutans was illuminated by Salehi et al. . Atchudan et al. explained the applications of N-doped TiO2 nanoparticles in cell imaging due to their good biocompatibility . Li et al. studied the photokilling effect of N-doped TiO2 nanoparticles on cancer cells .
15-1	1919-1927	Moreover	_	_	_	_
15-2	1928-1929	,	_	_	_	_
15-3	1930-1933	the	abstract[100]	new[100]	_	_
15-4	1934-1944	assessment	abstract[100]	new[100]	_	_
15-5	1945-1947	of	abstract[100]	new[100]	_	_
15-6	1948-1959	orthodontic	abstract[100]|object[101]	new[100]|new[101]	_	_
15-7	1960-1968	brackets	abstract[100]|object[101]	new[100]|new[101]	_	_
15-8	1969-1975	coated	_	_	_	_
15-9	1976-1980	with	_	_	_	_
15-10	1981-1988	N-doped	object[103]	giv[103]	coref	15-30[109_103]
15-11	1989-1993	TiO2	abstract|object[103]	giv|giv[103]	coref	15-31
15-12	1994-2007	nanoparticles	object[103]	giv[103]	_	_
15-13	2008-2015	against	object[103]	giv[103]	_	_
15-14	2016-2029	Streptococcus	object[103]|abstract|animal[105]	giv[103]|new|new[105]	_	_
15-15	2030-2036	mutans	object[103]|animal[105]	giv[103]|new[105]	_	_
15-16	2037-2040	was	_	_	_	_
15-17	2041-2052	illuminated	_	_	_	_
15-18	2053-2055	by	_	_	_	_
15-19	2056-2062	Salehi	person	new	_	_
15-20	2063-2065	et	_	_	_	_
15-21	2066-2069	al.	_	_	_	_
15-22	2070-2071	.	_	_	_	_
15-23	2072-2080	Atchudan	_	_	_	_
15-24	2081-2083	et	_	_	_	_
15-25	2084-2087	al.	_	_	_	_
15-26	2088-2097	explained	_	_	_	_
15-27	2098-2101	the	abstract[107]	new[107]	_	_
15-28	2102-2114	applications	abstract[107]	new[107]	_	_
15-29	2115-2117	of	abstract[107]	new[107]	_	_
15-30	2118-2125	N-doped	abstract[107]|object[109]	new[107]|giv[109]	ana	15-38[0_109]
15-31	2126-2130	TiO2	abstract[107]|abstract|object[109]	new[107]|giv|giv[109]	coref	15-51
15-32	2131-2144	nanoparticles	abstract[107]|object[109]	new[107]|giv[109]	_	_
15-33	2145-2147	in	abstract[107]|object[109]	new[107]|giv[109]	_	_
15-34	2148-2152	cell	abstract[107]|object[109]|place|abstract[111]	new[107]|giv[109]|giv|new[111]	_	_
15-35	2153-2160	imaging	abstract[107]|object[109]|abstract[111]	new[107]|giv[109]|new[111]	_	_
15-36	2161-2164	due	abstract[107]|object[109]|abstract[111]	new[107]|giv[109]|new[111]	_	_
15-37	2165-2167	to	_	_	_	_
15-38	2168-2173	their	object|abstract[113]	giv|giv[113]	coref|coref	15-50[117_0]|15-50[117_0]
15-39	2174-2178	good	abstract[113]	giv[113]	_	_
15-40	2179-2195	biocompatibility	abstract[113]	giv[113]	_	_
15-41	2196-2197	.	_	_	_	_
15-42	2198-2200	Li	person	new	_	_
15-43	2201-2203	et	_	_	_	_
15-44	2204-2207	al.	_	_	_	_
15-45	2208-2215	studied	_	_	_	_
15-46	2216-2219	the	abstract[115]	new[115]	_	_
15-47	2220-2232	photokilling	abstract[115]	new[115]	_	_
15-48	2233-2239	effect	abstract[115]	new[115]	_	_
15-49	2240-2242	of	abstract[115]	new[115]	_	_
15-50	2243-2250	N-doped	abstract[115]|object[117]	new[115]|giv[117]	coref	16-21[127_117]
15-51	2251-2255	TiO2	abstract[115]|abstract|object[117]	new[115]|giv|giv[117]	coref	16-24
15-52	2256-2269	nanoparticles	abstract[115]|object[117]	new[115]|giv[117]	_	_
15-53	2270-2272	on	abstract[115]|object[117]	new[115]|giv[117]	_	_
15-54	2273-2279	cancer	abstract[115]|object[117]|abstract|object[119]	new[115]|giv[117]|giv|new[119]	_	_
15-55	2280-2285	cells	abstract[115]|object[117]|object[119]	new[115]|giv[117]|new[119]	_	_
15-56	2286-2287	.	_	_	_	_

#Text=The purpose of the present study was to complement the vacuum in literature regarding exploration of comprehensive biological potential of N-doped and undoped TiO2 nanoparticles .
16-1	2288-2291	The	abstract[120]	new[120]	_	_
16-2	2292-2299	purpose	abstract[120]	new[120]	_	_
16-3	2300-2302	of	abstract[120]	new[120]	_	_
16-4	2303-2306	the	abstract[120]|abstract[121]	new[120]|new[121]	_	_
16-5	2307-2314	present	abstract[120]|abstract[121]	new[120]|new[121]	_	_
16-6	2315-2320	study	abstract[120]|abstract[121]	new[120]|new[121]	_	_
16-7	2321-2324	was	_	_	_	_
16-8	2325-2327	to	_	_	_	_
16-9	2328-2338	complement	_	_	_	_
16-10	2339-2342	the	abstract[122]	new[122]	_	_
16-11	2343-2349	vacuum	abstract[122]	new[122]	_	_
16-12	2350-2352	in	_	_	_	_
16-13	2353-2363	literature	abstract	new	_	_
16-14	2364-2373	regarding	_	_	_	_
16-15	2374-2385	exploration	abstract[124]	new[124]	_	_
16-16	2386-2388	of	abstract[124]	new[124]	_	_
16-17	2389-2402	comprehensive	abstract[124]|abstract[125]	new[124]|new[125]	ana	17-6[0_125]
16-18	2403-2413	biological	abstract[124]|abstract[125]	new[124]|new[125]	_	_
16-19	2414-2423	potential	abstract[124]|abstract[125]	new[124]|new[125]	_	_
16-20	2424-2426	of	abstract[124]|abstract[125]	new[124]|new[125]	_	_
16-21	2427-2434	N-doped	abstract[124]|abstract[125]|object[127]	new[124]|new[125]|giv[127]	coref	17-19[136_127]
16-22	2435-2438	and	abstract[124]|abstract[125]|object[127]	new[124]|new[125]|giv[127]	_	_
16-23	2439-2446	undoped	abstract[124]|abstract[125]|object[127]	new[124]|new[125]|giv[127]	_	_
16-24	2447-2451	TiO2	abstract[124]|abstract[125]|substance|object[127]	new[124]|new[125]|giv|giv[127]	coref	17-16
16-25	2452-2465	nanoparticles	abstract[124]|abstract[125]|object[127]	new[124]|new[125]|giv[127]	_	_
16-26	2466-2467	.	_	_	_	_

#Text=According to our knowledge , this is the first report covering multifunctional role of bare TiO2 nanoparticles and N-doped TiO2 nanoparticles in biomedicine .
17-1	2468-2477	According	_	_	_	_
17-2	2478-2480	to	_	_	_	_
17-3	2481-2484	our	person|abstract[129]	acc|new[129]	_	_
17-4	2485-2494	knowledge	abstract[129]	new[129]	_	_
17-5	2495-2496	,	_	_	_	_
17-6	2497-2501	this	abstract	giv	coref	17-8[131_0]
17-7	2502-2504	is	_	_	_	_
17-8	2505-2508	the	abstract[131]	giv[131]	_	_
17-9	2509-2514	first	abstract[131]	giv[131]	_	_
17-10	2515-2521	report	abstract[131]	giv[131]	_	_
17-11	2522-2530	covering	_	_	_	_
17-12	2531-2546	multifunctional	abstract[132]	giv[132]	_	_
17-13	2547-2551	role	abstract[132]	giv[132]	_	_
17-14	2552-2554	of	abstract[132]	giv[132]	_	_
17-15	2555-2559	bare	abstract[132]|object[134]	giv[132]|new[134]	_	_
17-16	2560-2564	TiO2	abstract[132]|abstract|object[134]	giv[132]|giv|new[134]	coref	17-20
17-17	2565-2578	nanoparticles	abstract[132]|object[134]	giv[132]|new[134]	_	_
17-18	2579-2582	and	abstract[132]	giv[132]	_	_
17-19	2583-2590	N-doped	abstract[132]|object[136]	giv[132]|giv[136]	coref	19-4[149_136]
17-20	2591-2595	TiO2	abstract[132]|abstract|object[136]	giv[132]|giv|giv[136]	coref	19-7
17-21	2596-2609	nanoparticles	abstract[132]|object[136]	giv[132]|giv[136]	_	_
17-22	2610-2612	in	abstract[132]|object[136]	giv[132]|giv[136]	_	_
17-23	2613-2624	biomedicine	abstract[132]|object[136]|abstract	giv[132]|giv[136]|new	_	_
17-24	2625-2626	.	_	_	_	_

#Text=Antibacterial , antifungal , antioxidant , antidiabetic , protein kinase inhibition and cytotoxicity assays have been carried out under in vitro conditions .
18-1	2627-2640	Antibacterial	_	_	_	_
18-2	2641-2642	,	_	_	_	_
18-3	2643-2653	antifungal	_	_	_	_
18-4	2654-2655	,	_	_	_	_
18-5	2656-2667	antioxidant	substance	new	_	_
18-6	2668-2669	,	_	_	_	_
18-7	2670-2682	antidiabetic	abstract	new	_	_
18-8	2683-2684	,	_	_	_	_
18-9	2685-2692	protein	substance	new	_	_
18-10	2693-2699	kinase	abstract|abstract[142]	new|new[142]	_	_
18-11	2700-2710	inhibition	abstract[142]	new[142]	_	_
18-12	2711-2714	and	_	_	_	_
18-13	2715-2727	cytotoxicity	abstract|abstract[144]	giv|new[144]	_	_
18-14	2728-2734	assays	abstract[144]	new[144]	_	_
18-15	2735-2739	have	_	_	_	_
18-16	2740-2744	been	_	_	_	_
18-17	2745-2752	carried	_	_	_	_
18-18	2753-2756	out	_	_	_	_
18-19	2757-2762	under	_	_	_	_
18-20	2763-2765	in	_	_	_	_
18-21	2766-2771	vitro	organization|abstract[146]	new|new[146]	_	_
18-22	2772-2782	conditions	abstract[146]	new[146]	_	_
18-23	2783-2784	.	_	_	_	_

#Text=Comparative assessment of undoped and N-doped TiO2 nanoparticles has been performed to exploit the effectivity of these nanoparticles to be used as drug-loading agents or carriers in nanomedicine for the cure of countless fatal diseases disrupting human health .
19-1	2785-2796	Comparative	abstract[147]	new[147]	_	_
19-2	2797-2807	assessment	abstract[147]	new[147]	_	_
19-3	2808-2810	of	abstract[147]	new[147]	_	_
19-4	2811-2818	undoped	abstract[147]|object[149]	new[147]|giv[149]	coref	19-17[151_149]
19-5	2819-2822	and	abstract[147]|object[149]	new[147]|giv[149]	_	_
19-6	2823-2830	N-doped	abstract[147]|object[149]	new[147]|giv[149]	_	_
19-7	2831-2835	TiO2	abstract[147]|abstract|object[149]	new[147]|giv|giv[149]	_	_
19-8	2836-2849	nanoparticles	abstract[147]|object[149]	new[147]|giv[149]	_	_
19-9	2850-2853	has	_	_	_	_
19-10	2854-2858	been	_	_	_	_
19-11	2859-2868	performed	_	_	_	_
19-12	2869-2871	to	_	_	_	_
19-13	2872-2879	exploit	_	_	_	_
19-14	2880-2883	the	abstract[150]	new[150]	_	_
19-15	2884-2895	effectivity	abstract[150]	new[150]	_	_
19-16	2896-2898	of	abstract[150]	new[150]	_	_
19-17	2899-2904	these	abstract[150]|object[151]	new[150]|giv[151]	_	_
19-18	2905-2918	nanoparticles	abstract[150]|object[151]	new[150]|giv[151]	_	_
19-19	2919-2921	to	_	_	_	_
19-20	2922-2924	be	_	_	_	_
19-21	2925-2929	used	_	_	_	_
19-22	2930-2932	as	_	_	_	_
19-23	2933-2945	drug-loading	_	_	_	_
19-24	2946-2952	agents	_	_	_	_
19-25	2953-2955	or	_	_	_	_
19-26	2956-2964	carriers	_	_	_	_
19-27	2965-2967	in	_	_	_	_
19-28	2968-2980	nanomedicine	object	new	_	_
19-29	2981-2984	for	_	_	_	_
19-30	2985-2988	the	event[153]	new[153]	_	_
19-31	2989-2993	cure	event[153]	new[153]	_	_
19-32	2994-2996	of	event[153]	new[153]	_	_
19-33	2997-3006	countless	event[153]|abstract[154]	new[153]|new[154]	_	_
19-34	3007-3012	fatal	event[153]|abstract[154]	new[153]|new[154]	_	_
19-35	3013-3021	diseases	event[153]|abstract[154]	new[153]|new[154]	_	_
19-36	3022-3032	disrupting	_	_	_	_
19-37	3033-3038	human	abstract[155]	new[155]	_	_
19-38	3039-3045	health	abstract[155]	new[155]	_	_
19-39	3046-3047	.	_	_	_	_
